Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.340
-0.110 (-7.59%)
Mar 18, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 148.66 million as of March 18, 2026. Its market cap has increased by 16.03% in one year.
Market Cap
148.66M
Enterprise Value
137.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.34
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 148.66M, an increase of 57.62%. That is a compound annual growth rate of 6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 160.86M | 23.39% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 277.68M |
| Aurora Cannabis | 269.37M |
| Organigram Global | 265.86M |
| BioSyent | 180.51M |
| Cannara Biotech | 176.82M |
| Auxly Cannabis Group | 168.60M |
| Ascend Wellness Holdings | 141.18M |
| HLS Therapeutics | 137.60M |